V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330007957 | 330004756 | 1.6 | 89.6 | Curative (C) | null | 2017-03-18 | Cetuximab + Radiotherapy Maint | null | null | 330013286 | CETUXIMAB + RT |
| 330007958 | 330004756 | 0 | 52 | Palliative (P) | 2016-12-04 | 2017-01-15 | Carboplatin + Etoposide iv&po | 02 | N | 330013286 | CARBOPLATIN + ETOPOSIDE |
| 330007959 | 330004756 | null | 62.2 | Not known (9) | 2015-09-23 | 2015-10-07 | Cetuximab + Radiotherapy Maint | N | N | 330013286 | CETUXIMAB + RT |
| 330007960 | 330004757 | null | null | Palliative (P) | 2016-10-12 | 2016-11-08 | Carboplatin+Fluorouracil 4 or 5 day | N | Y | 330013303 | CARBO + FLUOROURACIL |
| 330007961 | 330004758 | 1.75 | null | Curative (C) | 2014-05-31 | 2014-06-02 | PACLITAXEL | null | null | 330013306 | PACLITAXEL |
| 330007962 | 330004759 | 1.72 | null | Not known (9) | 2017-02-21 | 2017-03-09 | Cetuximab + Radiotherapy Maint | N | N | 330013308 | CETUXIMAB + RT |
| 330007963 | 330004762 | 1.6 | 43.8 | Curative (C) | 2015-06-08 | 2015-07-22 | VAI (Ifos 3g/m2) | N | Y | 330013309 | VAI |
| 330007964 | 330004763 | null | 77.2 | Palliative (P) | 2017-06-08 | 2017-06-25 | VAI (Ifos 3g/m2) | N | N | 330013311 | VAI |
| 330007965 | 330008594 | 1.78 | 71 | null | 2015-10-19 | 2016-04-11 | Carboplatin+Fluorouracil 4 or 5 day | 2 | Y | 330013316 | CARBO + FLUOROURACIL |
| 330007966 | 330004767 | 1.54 | 62.6 | Curative (C) | 2016-02-14 | 2016-03-03 | CARBOPLATIN + RT | N | N | 330013317 | CARBOPLATIN + RT |
| 330007967 | 330004768 | 1.73 | 57 | Curative (C) | 2014-07-24 | 2014-07-24 | CARBOPLATIN + PACLITAXEL | Y | N | 330013318 | CARBOPLATIN + PACLITAXEL |
| 330007968 | 330004769 | 1.56 | 104 | Curative (C) | 2015-01-27 | 2015-01-31 | CARBOPLATIN + RT | N | N | 330013320 | CARBOPLATIN + RT |
| 330007969 | 330004770 | null | 66 | Curative (C) | null | 2016-07-10 | VAI (Ifos 3g/m2) | N | null | 330013323 | VAI |
| 330007970 | 330004771 | null | 19.9 | Disease modification (D) | 2014-03-22 | 2014-04-22 | Carboplatin + Paclitaxel (3 weekly) | N | null | 330013323 | CARBOPLATIN + PACLITAXEL |
| 330007971 | 330004771 | 1.57 | 65.8 | null | 2017-05-17 | 2017-05-20 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 330013323 | CARBO + FLUOROURACIL |
| 330007972 | 330011808 | 1.83 | 77.6 | Curative (C) | 2017-01-03 | 2017-01-04 | EURAMOS TRIAL | 2 | N | 330013329 | EURAMOS TRIAL |
| 330007973 | 330004772 | 1.83 | 80.7 | Palliative (P) | 2016-01-15 | 2016-06-09 | Carboplatin + Etoposide iv&po | N | N | 330013331 | CARBOPLATIN + ETOPOSIDE |
| 330007974 | 330004773 | 1.75 | 87.2 | Palliative (P) | 2016-01-27 | 2016-10-12 | CARBOPLATIN + PACLITAXEL | N | N | 330013345 | CARBOPLATIN + PACLITAXEL |
| 330007978 | 330004775 | 1.75 | 99 | Curative (C) | 2017-05-18 | 2017-05-18 | CARBOPLATIN + RT | 02 | N | 330013392 | CARBOPLATIN + RT |
| 330007979 | 330004776 | null | 123.3 | Curative (C) | 2016-08-05 | 2017-07-14 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330013393 | BENDAMUSTINE + RITUXIMAB |
| 330007982 | 330004777 | null | null | null | 2014-05-15 | 2014-08-09 | Cetuximab + Radiotherapy Maint | N | N | 330013480 | CETUXIMAB + RT |
| 330007983 | 330004777 | 1.79 | 91.6 | Disease modification (D) | 2016-02-16 | 2016-02-17 | BENDAMUSTINE + RITUXIMAB | N | N | 330013480 | BENDAMUSTINE + RITUXIMAB |
| 330007984 | 330004777 | 1.84 | 74.9 | Neo-adjuvant (N) | 2015-07-17 | 2015-08-10 | EURAMOS TRIAL | 02 | null | 330013480 | EURAMOS TRIAL |
| 330007985 | 330004777 | 1.5 | 104 | Curative (C) | 2017-01-15 | 2017-02-02 | EURAMOS TRIAL | 02 | N | 330013480 | EURAMOS TRIAL |
| 330007987 | 330004780 | 1.79 | 89.6 | Palliative (P) | 2013-07-30 | 2013-11-25 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330013513 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007988 | 330004782 | 1.75 | 77.7 | Palliative (P) | 2016-12-20 | 2017-04-03 | Paclitaxel 7 day | 02 | N | 330013532 | PACLITAXEL |
| 330007989 | 330004782 | 1.05 | 93.4 | Curative (C) | null | 2018-03-02 | VAI (Ifos 3g/m2) | 02 | N | 330013532 | VAI |
| 330007990 | 330004785 | 1.9 | 103.5 | Neo-adjuvant (N) | 2018-07-27 | 2018-08-31 | CARBOPLATIN + PACLITAXEL | 02 | N | 330013561 | CARBOPLATIN + PACLITAXEL |
| 330007992 | 330004787 | 1.82 | 80.4 | Neo-adjuvant (N) | 2016-06-26 | 2016-11-20 | ALL UKALL2011 Del Int A Pt1 (PAsp) | N | N | 330013586 | UKALL2011 |
| 330007993 | 330004788 | 1.9 | 77 | Curative (C) | 2013-09-01 | 2014-02-28 | EURAMOS TRIAL | Y | N | 330013618 | EURAMOS TRIAL |
| 330007994 | 330004789 | 1.7 | 94 | Palliative (P) | 2015-06-13 | 2015-06-24 | Paclitaxel (2 or 3 weekly) | 02 | Y | 330013618 | PACLITAXEL |
| 330007995 | 330008609 | 1.89 | 81 | Curative (C) | 2013-10-14 | 2013-10-14 | Carboplatin + Etoposide iv&po | 02 | N | 330013620 | CARBOPLATIN + ETOPOSIDE |
| 330007996 | 330008609 | 1.6 | null | Neo-adjuvant (N) | 2014-06-04 | 2014-06-04 | BENDAMUSTINE + RITUXIMAB | N | N | 330013620 | BENDAMUSTINE + RITUXIMAB |
| 330007997 | 330008610 | 1.67 | 63.1 | Not known (9) | 2013-01-28 | 2013-01-30 | Cetuximab + Radiotherapy Load | N | N | 330013660 | CETUXIMAB + RT |
| 330007998 | 330004792 | 1.61 | 82.9 | Neo-adjuvant (N) | 2013-09-30 | 2013-11-27 | CARBOPLATIN + PACLITAXEL | N | N | 330013675 | CARBOPLATIN + PACLITAXEL |
| 330007999 | 330004793 | 1.59 | null | Disease modification (D) | 2013-07-30 | 2013-08-20 | ALL UKALL2011 (ProtM-A) C PegAsp | 02 | N | 330013680 | UKALL2011 |
| 330008002 | 330010666 | 1.56 | 99.6 | Neo-adjuvant (N) | 2014-07-05 | 2014-07-09 | EURAMOS TRIAL | 01 | N | 330013711 | EURAMOS TRIAL |
| 330008004 | 330011814 | 1.78 | 57 | Palliative (P) | 2017-03-20 | 2017-03-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330013738 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330008005 | 330011814 | 1.89 | 19.7 | Disease modification (D) | 2016-06-17 | 2016-06-17 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330013738 | BENDAMUSTINE + RITUXIMAB |
| 330008006 | 330004801 | 1.57 | 38.4 | Neo-adjuvant (N) | 2015-12-28 | 2016-08-31 | Paclitaxel 7 day | 02 | N | 330013757 | PACLITAXEL |
| 330008007 | 330004801 | 1.66 | 63.3 | Neo-adjuvant (N) | 2017-06-18 | 2017-06-21 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330013757 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330008008 | 330004802 | 1.73 | 58 | Curative (C) | null | 2018-08-01 | Carboplatin + Etoposide iv&po | null | null | 330013778 | CARBOPLATIN + ETOPOSIDE |
| 330008009 | 330004803 | 1.52 | null | Palliative (P) | 2013-06-28 | 2013-07-23 | BENDAMUSTINE + RITUXIMAB | N | Y | 330013778 | BENDAMUSTINE + RITUXIMAB |
| 330008010 | 330004804 | 1.69 | 108.2 | Palliative (P) | 2014-08-31 | 2014-10-19 | Carboplatin+Fluorouracil 4 or 5 day | N | Y | 330013793 | CARBO + FLUOROURACIL |
| 330008011 | 330004804 | 0 | 84 | Disease modification (D) | 2013-09-13 | 2014-01-14 | CARBOPLATIN + RT | N | N | 330013793 | CARBOPLATIN + RT |
| 330008012 | 330004805 | 1.72 | 72 | Neo-adjuvant (N) | 2015-10-15 | 2015-10-15 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 330013821 | BENDAMUSTINE + RITUXIMAB |
| 330008013 | 330004806 | 1.59 | 43.8 | Neo-adjuvant (N) | 2017-06-26 | 2017-07-01 | EURAMOS TRIAL | N | N | 330013824 | EURAMOS TRIAL |
| 330008014 | 330004806 | 0 | 59.8 | Curative (C) | 2016-02-07 | 2016-02-10 | CARBOPLATIN + RT | N | N | 330013824 | CARBOPLATIN + RT |
| 330008015 | 330004807 | null | 15.2 | Curative (C) | 2015-03-13 | 2015-03-13 | Cisplatin + Docetaxel +Fluorouracil | 1 | N | 330013832 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330008016 | 330004807 | 1.77 | 78 | Palliative (P) | 2017-07-25 | 2017-07-31 | Paclitaxel 7 day | 02 | N | 330013832 | PACLITAXEL |